Microsure | Top Medtech Startup in Europe 2022

MedTech Outlook Magazine

Microsure
MUSA

Sjaak Deckers, CEO, MicrosureSjaak Deckers, CEO
Apart from artificial intelligence, virtual reality, and precision manufacturing, another technology that is changing the status quo of Europe’s medtech arena is robot-assisted surgical devices.

Robotic surgery or robot-assisted surgery empowers surgeons to perform a myriad of complex procedures with the levels of precision, control, and flexibility that are impractical with traditional surgical techniques. Usually associated with minimally invasive surgeries, surgical robots offer improved visibility that enhances the success of a surgery.

  • Our engineers have made tremendous improvements to the current MUSA system, and our clinical team gained further adoption experience of microsurgery in the Netherlands with the MUSA system


A company at the forefront of innovation in Europe’s robotic surgery arena is Microsure.

Microsure is an Eindhoven-based medical device company that improves patients’ lives with its robot systems for microsurgeries. Founded by the Eindhoven University of Technology and Maastricht University Medical Center in 2016, the company has emerged as a force to be reckoned with and transformed the region’s medtech sector. Microsure has an excellent track record in commercial, technical, and clinical domains, along with strategic collaborations with clinical key opinion leaders, regulatory and quality experts, and industrial partners.
The company is built on a network of technical and clinical advisors and top surgeons from university medical centers worldwide, with the Maastricht University Medical Center+ as a leading clinical partner. With a dynamic team of experts with longstanding experience in the medtech sector, Microsure is changing lives around the world and improving the efficiency of surgeries. Its flagship product MUSA – the world’s first clinically available CE-certified surgical robot for open microsurgery – is taking the global medtech community by storm.

Microsure has developed MUSA in close cooperation with microsurgeons and engineers, specially geared towards microsurgeries. MUSA renders extraordinary levels of precision, enabling new interventions that are currently not feasible with conventional methods. MUSA is compatible with existing operating techniques, OR-equipment, and instruments, making it seamless and effortless for surgeons to operate on it. The solution leaves a small footprint on the OR, as the infrastructure and flow remain unchanged during usage. MUSA’s setup allows hybrid microsurgical procedures as surgeons are seated next to patients, assistants, and OR staff. Surgeons can keep their hands tremor free and steady throughout a surgery. MUSA can be controlled via a joystick while working in a comfortable and ergonomic position – this reduces fatigue and pain for the surgeons apropos of surgical procedures. MUSA has transformed lymphatic, free-flap, and hand surgeries, enhancing microsurgical processes and enabling nascent interventions. Owing to such an innovative product, Microsure has garnered a lot of attention from several key sites and users from Europe. The company was also able to proactively respond to the ongoing covid-19 pandemic, upgrading its existing products to cater to dynamic market scenarios. “Despite the Covid-19 restrictions, our engineers have made tremendous improvements to the current MUSA system, and our clinical team gained further adoption experience of microsurgery in the Netherlands with the MUSA system,” says Sjaak Deckers, CEO of Microsure. Looking forward, Microsure aims to offer high-quality surgical performance for multiple surgical devices, reducing inter operator variability and enabling safer operations, improved patient safety, and operational outcomes. It is evident that Microsure will execute the paradigm shift required to transform the global microsurgery arena, proactively addressing emerging challenges and reading the sector for unprecedented events in the future.

Top 10 Medtech Startups in Europe - 2022

Company
Microsure

Management
Sjaak Deckers, CEO

Description
Microsure is a medical device company located in Eindhoven, founded by Eindhoven University of Technology and Maastricht University Medical Center in 2016. The company focuses on improving patients’ lives through developing robot systems for microsurgery

Microsure News

Microsure Nabs €38M Series B2 Funding for Microsurgical Robot

The funding with go towards the development of MUSA-3 for clinical study and, eventually, FDA clearance and CE-mark certification.
Microsure, a company focused on robot-assisted microsurgery, has closed its Series B2 investment round with €38 million in developmental capital from both new and existing investors. New investors include a grant from the European Innovation Council Fund, Kineo, Invest-NL, and several other private investor groups. Key existing shareholders that contributed to the funding round were Innovation Industries, BOM Ventures, Ten Crate Investerings Maatschappij, Venturing Tech, Eindhoven University of Technology, and Microsure Founders.
The company has also received an Innovation Loan from RvO, a division of the Dutch Ministry of Economic Affairs and have entered into an asset financing agreement with Kineo, enabling Microsure to offer appealing MUSA-3 leasing options to hospitals. As part of the funding round, Kreske Nickelsen from Kineo will join Microsure’s supervisory board.
The funding will help the company finalize the development of its newest microsurgical robot MUSA-3 for clinical studies, followed by FDA clearance and CE-mark certification. "Our progress is a testament to the exceptional talent within our growing team of dedicated individuals and the seamless collaboration with our key development and manufacturing partners,” said Sjaak Deckers, CEO of Microsure, in a press release. “The continued expansion of Microsure's clinical network strategically positions the company for upcoming clinical studies, an integral part of our journey towards securing FDA clearance and CE-mark certification."
MUSA-3 consists of a surgeon console and robotic arm cart that uses the surgeons own trusted instruments through disposable adapters during surgical procedures. The system is combined with a separate digital or hybrid microscope.
The robotic arm cart allows a surgeon to suture with high precision, dexterity, and stability, allowing for the navigation of various wound plane orientations. The surgeon console allows for the physician to sit comfortably while looking at the screen and controlling the robotic arm using joysticks. While using the joysticks, the system applies movement scaling and tremor filtering to increase precision.
MUSA-3 builds off the company’s previous MUSA-2 version, enhancing dexterity, and providing a wider workspace as well as introducing tremor reduction for enhanced precision and integrating surgeons existing preferred micro-instruments from different brands.
"We extend our deep gratitude to both our new and steadfast existing investors for their unwavering support, which has propelled Microsure to new heights,” Deckers said. “The financing will enable us to advance our groundbreaking technology and bring innovative solutions to patients worldwide through our MUSA-3 robotic system."